The COVID-19 pandemic thrusted the pharmaceutical industry into the global spotlight. Positive news on successful vaccine developments have been accompanied by grimmer updates that pharma companies are facing disproportionate levels of targeted malicious attacks. With valuable vaccine research data and information on how key medical goods are being supplied across the world, pharma firms are viewed as lucrative targets by cybercriminals lurking in the dark web. Read this case study to learn how the firm is using external threat landscape visibility to strengthen its cyber posture.
